Status:
COMPLETED
Effect of an Oral Therapeutic Patient Education Session on Physical Activity in Patients With Cancer
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Cancer
Eligibility:
All Genders
18-84 years
Phase:
NA
Brief Summary
Despite significant evolution of cancer therapies from the early 20th century, these therapies are still associated with toxic effects that negatively impact the patient's performance status, quality ...
Detailed Description
The investigators aim to compare the effects of two forms of TPE on the patient's PA level. In one of the two forms, TPE is delivered using an information booklet accompanied with a semi-structured or...
Eligibility Criteria
Inclusion
- Adults aged between 18 and 84 years
- Suffering from a first cancer, with the exception of the following cancers in the patient's history (provided that they have been successfully treated):
- non-melanoma skin cancer,
- carcinoma in situ of the uterine cervix
- ductal carcinoma in situ.
- Preserved performance status (ECOG scale ≤ 1),
- Starting one of the following systemic cancer therapies:
- chemotherapy,
- immunotherapy,
- targeted therapies,
- Able to understand and read French
- Life expectancy of at least 1 year
Exclusion
- Poor cognitive function (Mini-Mental State Examination ≤ 24/30)
- Having a recurrence of cancer, with the exception of the following cancers in the patient's history (provided that they have been successfully treated):
- non-melanoma skin cancer,
- carcinoma in situ of the uterine cervix,
- ductal carcinoma in situ.
Key Trial Info
Start Date :
December 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 29 2022
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT04665973
Start Date
December 7 2020
End Date
July 29 2022
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques universitaires Saint-Luc
Brussels, Belgium, 1200